NCT03767621
Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR No drug interventions Not Available Not Available active_not_recruiting NCT04968977
PCI vs. CABG in UPLM-ISR No drug interventions Not Available Not Available completed NCT00531011
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease No drug interventions treatment 4 completed NCT05860400
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study No drug interventions Not Available Not Available recruiting NCT00496938
XIENCE V: SPIRIT WOMEN No drug interventions treatment 4 completed NCT01759290
ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients. No drug interventions Not Available Not Available completed NCT00180479
SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) No drug interventions treatment 3 completed NCT01182428
XIENCE V: SPIRIT WOMEN Sub-study No drug interventions treatment 4 completed NCT01310309
EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease No drug interventions Not Available Not Available completed NCT06007248
Disease Characteristics of IR-CAD: a Case-control Study No drug interventions Not Available Not Available not_yet_recruiting NCT05093244
Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment No drug interventions treatment Not Available withdrawn NCT02300454
Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions No drug interventions treatment 4 unknown_status NCT03074305
DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold No drug interventions treatment Not Available withdrawn NCT00859183
Oral Sirolimus for In-Stent Restenosis treatment 4 completed NCT01331707
DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population No drug interventions treatment 4 completed NCT02474485
Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR No drug interventions treatment Not Available suspended NCT01894152
XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study No drug interventions Not Available Not Available completed NCT00376870
PIoglitazone for PrEvention of Restenosis in Diabetic Patients treatment 3 unknown_status NCT01967199
Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis No drug interventions treatment 4 terminated NCT02175706
DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity No drug interventions treatment Not Available unknown_status NCT00426049
Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation treatment 3 unknown_status NCT01274234
OCT Evaluation of Healing of COMBO Stent No drug interventions treatment 1 / 2 completed NCT01977534
To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels No drug interventions Not Available Not Available completed NCT00162357
Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty diagnostic 4 completed NCT00412126
Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI treatment Not Available completed NCT00180466
PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions No drug interventions Not Available Not Available completed NCT01915420
The ASSURE ROT Registry: Bioresorbable Vascular Scaffold Following Rotablation for Complex Coronary Lesions No drug interventions Not Available Not Available unknown_status NCT01171820
SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study) No drug interventions treatment 4 completed NCT00287573
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis No drug interventions treatment 2 / 3 completed NCT01249027
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study No drug interventions Not Available Not Available completed NCT01205776
EXCEL Clinical Trial No drug interventions treatment Not Available completed NCT04915391
Restenosis in Coronary Stents And Cutaneous HEaLing No drug interventions Not Available Not Available unknown_status NCT00752362
Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT) No drug interventions treatment 4 completed NCT01205789
EXCEL Clinical Trial (Universal Registry) No drug interventions Not Available Not Available completed NCT01023789
ABSORB EXTEND Clinical Investigation No drug interventions treatment Not Available completed NCT01178268
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT) No drug interventions treatment 4 completed NCT00180310
SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System No drug interventions treatment 3 completed NCT00055510
A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels. treatment 2 / 3 completed NCT02508714
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents No drug interventions treatment Not Available unknown_status NCT04494750
Physiology and Residual Ischemia After Percutaneous Coronary Intervention No drug interventions Not Available Not Available unknown_status NCT01066650
The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente No drug interventions treatment 4 completed NCT00243308
Serp-1 for the Treatment of Acute Coronary Syndrome diagnostic 2 terminated NCT01583608
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease No drug interventions Not Available Not Available completed NCT00124943
Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis treatment 1 / 2 completed NCT01262703
Safety Study of a Bioresorbable Coronary Stent No drug interventions treatment Not Available completed NCT01674803
Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT) No drug interventions treatment Not Available completed NCT02944890
Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis No drug interventions treatment Not Available completed NCT01651390
Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis. No drug interventions treatment Not Available completed NCT00500279
Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial treatment 4 unknown_status NCT00106587
Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I) treatment 1 / 2 completed NCT01115933
A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population No drug interventions treatment Not Available completed NCT00714545
SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents No drug interventions treatment 4 completed NCT05471245
AnGiographic Performance With A Sirolimus-elutiNG Balloon in the TrEatment of De Novo CoronaRy Artery Disease No drug interventions treatment Not Available recruiting NCT00631228
XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study No drug interventions Not Available Not Available completed NCT01086228
XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan No drug interventions Not Available Not Available completed NCT00856856
ABSORB Clinical Investigation, Cohort B No drug interventions treatment Not Available completed NCT00148356
Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries No drug interventions treatment 2 / 3 completed NCT04988685
SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters No drug interventions Not Available Not Available recruiting NCT00916370
SPIRIT PRIME Clinical Trial No drug interventions treatment 3 completed NCT01269242
The Effects of Bindarit in Preventing Stent Restenosis prevention 2 completed NCT02263313
EGO-COMBO Clinical End-point Extension Study Beyond 36 Months No drug interventions Not Available Not Available completed NCT03667313
Treatment of In-Stent Restenosis 2 Study treatment 3 completed NCT00882219
Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period No drug interventions treatment 3 completed NCT01106534
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort treatment 4 completed NCT03242096
Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon treatment Not Available completed NCT00248066
Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries No drug interventions treatment 2 completed NCT00300131
ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation No drug interventions Not Available Not Available completed NCT04475380
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents No drug interventions Not Available Not Available active_not_recruiting NCT04280029
SELUTION SLR™ 014 In-stent Restenosis No drug interventions treatment Not Available active_not_recruiting NCT00140101
Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries No drug interventions prevention 2 completed NCT00402272
SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe No drug interventions treatment 4 completed NCT00552669
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents health_services_research 4 completed NCT02151812
Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR) No drug interventions treatment Not Available completed NCT00589810
Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal No drug interventions Not Available Not Available completed NCT00409981
Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II) No drug interventions treatment 1 / 2 completed NCT02367495
Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES No drug interventions treatment Not Available completed NCT00714623
The SCRIPPS DES REAL WORLD Registry No drug interventions Not Available Not Available completed NCT05089864
STAR and Deferred Stenting Study No drug interventions treatment Not Available recruiting NCT06075602
COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease No drug interventions Not Available Not Available recruiting NCT01120379
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort) No drug interventions Not Available Not Available completed